Monteverde & Associates Begins Investigation Into Soleno Therapeutics Shareholder Deal Fairness The M&A Class Action Firm, led by Juan Monteverde, investigates Soleno Therapeutics' acquisition by Neurocrine Biosciences, seeking shareholder fair compensation.

Monteverde & Associates Begins Investigation Into Soleno Therapeutics Shareholder Deal Fairness #New_York #Monteverde_Associates #United_States_of_America #Soleno_Therapeutics #NASDAQ_SLNO